ACOG Recommends Salpingectomy Over Tubal Ligation to Reduce Ovarian Cancer Risk
Salpingectomy Versus Traditional Tubal Ligation
Traditional tubal ligation involves cutting, tying, or sealing the fallopian tubes to prevent pregnancy. In contrast, a salpingectomy removes the tubes completely, eliminating both pregnancy potential and the primary tissue site where aggressive ovarian cancers originate. Research demonstrates that approximately 70 percent of the most common and aggressive forms of ovarian cancer start in the fallopian tubes. Because ovarian cancer is exceptionally difficult to detect early and lacks reliable screening tests, ACOG guidelines now state that salpingectomy is the preferred procedure for patients seeking permanent contraception.
Opportunistic Salpingectomy During Other Surgeries
The updated guidance also encourages clinicians to discuss opportunistic salpingectomy with patients undergoing other scheduled abdominal or pelvic procedures. According to ACOG, surgeons can remove the fallopian tubes during operations like hysterectomies, uterine fibroid removals, or ovarian cyst surgeries without increasing recovery time or surgical risks. This preventative strategy extends to non-gynecological operations in the pelvis or abdomen, such as gallbladder removal, appendectomies, hernia repairs, or bowel surgery, provided the patient does not wish to have children in the future.
Expert Perspective and Patient Options

Dr. David Schalowitz, a professor at Western Michigan University’s medical school, emphasized the clinical impact of the updated guidance in a public statement. Obstetrician-gynecologists have an opportunity to empower patients through education, evidence-based practice, and collaboration with other medical and surgical specialists,
Dr. Schalowitz noted. For now, salpingectomy is the safest, most effective way to prevent this deadly disease.
Patients who wish to preserve fertility can explore alternative options such as the oral contraceptive pill, which clinical studies associate with a reduction in long-term ovarian cancer risk.
